pcDNA3.1 PA-NL Citations (2)
Originally described in: LuTHy: a double-readout bioluminescence-based two-hybrid technology for quantitative mapping of protein-protein interactions in mammalian cells.Trepte P, Kruse S, Kostova S, Hoffmann S, Buntru A, Tempelmeier A, Secker C, Diez L, Schulz A, Klockmeier K, Zenkner M, Golusik S, Rau K, Schnoegl S, Garner CC, Wanker EE Mol Syst Biol. 2018 Jul 11;14(7):e8071. doi: 10.15252/msb.20178071. PubMed Journal
Articles Citing pcDNA3.1 PA-NL
| Articles |
|---|
| Dynamics of huntingtin protein interactions in the striatum identifies candidate modifiers of Huntington disease. Greco TM, Secker C, Ramos ES, Federspiel JD, Liu JP, Perez AM, Al-Ramahi I, Cantle JP, Carroll JB, Botas J, Zeitlin SO, Wanker EE, Cristea IM. Cell Syst. 2022 Apr 20;13(4):304-320.e5. doi: 10.1016/j.cels.2022.01.005. Epub 2022 Feb 10. PubMed |
| AI-guided pipeline for protein-protein interaction drug discovery identifies a SARS-CoV-2 inhibitor. Trepte P, Secker C, Olivet J, Blavier J, Kostova S, Maseko SB, Minia I, Silva Ramos E, Cassonnet P, Golusik S, Zenkner M, Beetz S, Liebich MJ, Scharek N, Schutz A, Sperling M, Lisurek M, Wang Y, Spirohn K, Hao T, Calderwood MA, Hill DE, Landthaler M, Choi SG, Twizere JC, Vidal M, Wanker EE. Mol Syst Biol. 2024 Apr;20(4):428-457. doi: 10.1038/s44320-024-00019-8. Epub 2024 Mar 11. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.